ID   PTSS1_HUMAN             Reviewed;         473 AA.
AC   P48651; B4DE85; E5RFC5; Q9BUQ5;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   15-MAR-2017, entry version 137.
DE   RecName: Full=Phosphatidylserine synthase 1;
DE            Short=PSS-1;
DE            Short=PtdSer synthase 1;
DE            EC=2.7.8.29;
DE   AltName: Full=Serine-exchange enzyme I;
GN   Name=PTDSS1; Synonyms=KIAA0024, PSSA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=7584026; DOI=10.1093/dnares/1.1.27;
RA   Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y.,
RA   Sato S., Nagase T., Seki N., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. I.
RT   The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by
RT   analysis of randomly sampled cDNA clones from human immature myeloid
RT   cell line KG-1.";
RL   DNA Res. 1:27-35(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, Lymph, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   ENZYME REGULATION.
RX   PubMed=9539713; DOI=10.1073/pnas.95.8.4199;
RA   Kuge O., Hasegawa K., Saito K., Nishijima M.;
RT   "Control of phosphatidylserine biosynthesis through
RT   phosphatidylserine-mediated inhibition of phosphatidylserine synthase
RT   I in Chinese hamster ovary cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:4199-4203(1998).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-442, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-417 AND SER-425, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   SUBSTRATE SPECIFICITY, ENZYME REGULATION, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=19014349; DOI=10.1042/BJ20081597;
RA   Tomohiro S., Kawaguti A., Kawabe Y., Kitada S., Kuge O.;
RT   "Purification and characterization of human phosphatidylserine
RT   synthases 1 and 2.";
RL   Biochem. J. 418:421-429(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-442, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-442 AND SER-454, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-417 AND SER-425, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   VARIANTS LMHD PRO-265; SER-269 AND ARG-353, AND CHARACTERIZATION OF
RP   VARIANTS LMHD PRO-265; SER-269 AND ARG-353.
RX   PubMed=24241535; DOI=10.1038/ng.2829;
RA   Sousa S.B., Jenkins D., Chanudet E., Tasseva G., Ishida M.,
RA   Anderson G., Docker J., Ryten M., Sa J., Saraiva J.M., Barnicoat A.,
RA   Scott R., Calder A., Wattanasirichaigoon D., Chrzanowska K.,
RA   Simandlova M., Van Maldergem L., Stanier P., Beales P.L., Vance J.E.,
RA   Moore G.E.;
RT   "Gain-of-function mutations in the phosphatidylserine synthase 1
RT   (PTDSS1) gene cause Lenz-Majewski syndrome.";
RL   Nat. Genet. 46:70-76(2014).
CC   -!- FUNCTION: Catalyzes a base-exchange reaction in which the polar
CC       head group of phosphatidylethanolamine (PE) or phosphatidylcholine
CC       (PC) is replaced by L-serine. In membranes, PTDSS1 catalyzes
CC       mainly the conversion of phosphatidylcholine. Also converts, in
CC       vitro and to a lesser extent, phosphatidylethanolamine.
CC   -!- CATALYTIC ACTIVITY: L-1-phosphatidylethanolamine + L-serine = L-1-
CC       phosphatidylserine + ethanolamine.
CC   -!- ENZYME REGULATION: Requires calcium ions. Activated by exogenous
CC       phosphatidylethanolamine. {ECO:0000269|PubMed:19014349,
CC       ECO:0000269|PubMed:9539713}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=67 uM for serine (in the presence of 2 mM PC)
CC         {ECO:0000269|PubMed:19014349};
CC         KM=24 uM for serine (in the presence of 1 mM PE)
CC         {ECO:0000269|PubMed:19014349};
CC       pH dependence:
CC         Optimum pH for both PC and PE is between 7.0 and 7.5.
CC         {ECO:0000269|PubMed:19014349};
CC   -!- PATHWAY: Phospholipid metabolism; phosphatidylserine biosynthesis.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.
CC       Note=Highly enriched in the mitochondria-associated membrane
CC       (MAM). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P48651-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P48651-2; Sequence=VSP_055980;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P48651-3; Sequence=VSP_057421, VSP_057422;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Lenz-Majewski hyperostotic dwarfism (LMHD) [MIM:151050]:
CC       A syndrome of intellectual disability and multiple congenital
CC       anomalies that features generalized craniotubular hyperostosis.
CC       LMHD is characterized by the combination of sclerosing bone
CC       dysplasia, intellectual disability and distinct craniofacial,
CC       dental, cutaneous and distal limb anomalies. The progressive
CC       generalized hyperostosis associated with this syndrome affects the
CC       cranium, the vertebrae and the diaphyses of tubular bones, leading
CC       to severe growth restriction. {ECO:0000269|PubMed:24241535}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the phosphatidyl serine synthase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D14694; BAA03520.1; -; mRNA.
DR   EMBL; AK293513; BAG56996.1; -; mRNA.
DR   EMBL; AP003465; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC877275; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC004192; AAH04192.1; -; mRNA.
DR   EMBL; BC002376; AAH02376.2; -; mRNA.
DR   EMBL; BC004390; AAH04390.1; -; mRNA.
DR   CCDS; CCDS6271.1; -. [P48651-1]
DR   RefSeq; NP_001277154.1; NM_001290225.1. [P48651-2]
DR   RefSeq; NP_055569.1; NM_014754.2. [P48651-1]
DR   UniGene; Hs.292579; -.
DR   ProteinModelPortal; P48651; -.
DR   BioGrid; 115135; 13.
DR   IntAct; P48651; 12.
DR   STRING; 9606.ENSP00000430548; -.
DR   DrugBank; DB00144; Phosphatidyl serine.
DR   SwissLipids; SLP:000001060; -.
DR   iPTMnet; P48651; -.
DR   PhosphoSitePlus; P48651; -.
DR   BioMuta; PTDSS1; -.
DR   DMDM; 1346881; -.
DR   EPD; P48651; -.
DR   MaxQB; P48651; -.
DR   PaxDb; P48651; -.
DR   PeptideAtlas; P48651; -.
DR   PRIDE; P48651; -.
DR   DNASU; 9791; -.
DR   Ensembl; ENST00000517309; ENSP00000430548; ENSG00000156471. [P48651-1]
DR   Ensembl; ENST00000522072; ENSP00000430928; ENSG00000156471. [P48651-3]
DR   GeneID; 9791; -.
DR   KEGG; hsa:9791; -.
DR   UCSC; uc003yht.2; human. [P48651-1]
DR   UCSC; uc064ouh.1; human.
DR   CTD; 9791; -.
DR   DisGeNET; 9791; -.
DR   GeneCards; PTDSS1; -.
DR   HGNC; HGNC:9587; PTDSS1.
DR   HPA; HPA016852; -.
DR   MalaCards; PTDSS1; -.
DR   MIM; 151050; phenotype.
DR   MIM; 612792; gene.
DR   neXtProt; NX_P48651; -.
DR   OpenTargets; ENSG00000156471; -.
DR   Orphanet; 2658; Lenz-Majewski hyperostotic dwarfism.
DR   PharmGKB; PA33939; -.
DR   eggNOG; KOG2735; Eukaryota.
DR   eggNOG; ENOG410XS7H; LUCA.
DR   GeneTree; ENSGT00530000063576; -.
DR   HOGENOM; HOG000069882; -.
DR   HOVERGEN; HBG053765; -.
DR   InParanoid; P48651; -.
DR   KO; K08729; -.
DR   OMA; SGNNESH; -.
DR   OrthoDB; EOG091G075F; -.
DR   PhylomeDB; P48651; -.
DR   TreeFam; TF300012; -.
DR   BioCyc; MetaCyc:HS08129-MONOMER; -.
DR   Reactome; R-HSA-1483101; Synthesis of PS.
DR   UniPathway; UPA00948; -.
DR   ChiTaRS; PTDSS1; human.
DR   GenomeRNAi; 9791; -.
DR   PRO; PR:P48651; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000156471; -.
DR   CleanEx; HS_PTDSS1; -.
DR   ExpressionAtlas; P48651; baseline and differential.
DR   Genevisible; P48651; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0016740; F:transferase activity; TAS:Reactome.
DR   GO; GO:0006659; P:phosphatidylserine biosynthetic process; TAS:Reactome.
DR   InterPro; IPR004277; PSS.
DR   Pfam; PF03034; PSS; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome;
KW   Disease mutation; Dwarfism; Endoplasmic reticulum; Lipid biosynthesis;
KW   Lipid metabolism; Membrane; Mental retardation;
KW   Phospholipid biosynthesis; Phospholipid metabolism; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:25944712}.
FT   CHAIN         2    473       Phosphatidylserine synthase 1.
FT                                /FTId=PRO_0000056829.
FT   TOPO_DOM      2     35       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     36     56       Helical. {ECO:0000255}.
FT   TOPO_DOM     57     72       Lumenal. {ECO:0000255}.
FT   TRANSMEM     73     93       Helical. {ECO:0000255}.
FT   TOPO_DOM     94    102       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    103    123       Helical. {ECO:0000255}.
FT   TOPO_DOM    124    186       Lumenal. {ECO:0000255}.
FT   TRANSMEM    187    207       Helical. {ECO:0000255}.
FT   TOPO_DOM    208    216       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    217    237       Helical. {ECO:0000255}.
FT   TOPO_DOM    238    286       Lumenal. {ECO:0000255}.
FT   TRANSMEM    287    307       Helical. {ECO:0000255}.
FT   TOPO_DOM    308    319       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    320    342       Helical. {ECO:0000255}.
FT   TOPO_DOM    343    355       Lumenal. {ECO:0000255}.
FT   TRANSMEM    356    376       Helical. {ECO:0000255}.
FT   TOPO_DOM    377    383       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    384    404       Helical. {ECO:0000255}.
FT   TOPO_DOM    405    473       Lumenal. {ECO:0000255}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:25944712}.
FT   MOD_RES     417    417       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     425    425       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     442    442       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     454    454       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   VAR_SEQ       1    203       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057421.
FT   VAR_SEQ       1    146       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_055980.
FT   VAR_SEQ     449    473       NNESHSSRRRNRHSKSKVTNGVGKK -> EGTWGSLFEIVS
FT                                LVSHRPGRVRQIIAWGAFANVGSLLTSALDMRSPVAARCVE
FT                                GKR (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057422.
FT   VARIANT     265    265       L -> P (in LMHD; does not affect protein
FT                                levels; increases the rate of
FT                                phosphatidylserine synthesis; profoundly
FT                                impairs negative feedback enzyme
FT                                regulation by phosphatidylserine;
FT                                dbSNP:rs587777090).
FT                                {ECO:0000269|PubMed:24241535}.
FT                                /FTId=VAR_070987.
FT   VARIANT     269    269       P -> S (in LMHD; does not affect protein
FT                                levels; increases the rate of
FT                                phosphatidylserine synthesis; profoundly
FT                                impairs negative feedback enzyme
FT                                regulation by phosphatidylserine;
FT                                dbSNP:rs587777089).
FT                                {ECO:0000269|PubMed:24241535}.
FT                                /FTId=VAR_070988.
FT   VARIANT     353    353       Q -> R (in LMHD; does not affect protein
FT                                levels; increases the rate of
FT                                phosphatidylserine synthesis; profoundly
FT                                impairs negative feedback enzyme
FT                                regulation by phosphatidylserine;
FT                                dbSNP:rs587777088).
FT                                {ECO:0000269|PubMed:24241535}.
FT                                /FTId=VAR_070989.
FT   VARIANT     423    423       T -> N (in dbSNP:rs7835798).
FT                                /FTId=VAR_048735.
SQ   SEQUENCE   473 AA;  55528 MW;  CFC8F50A33CE038D CRC64;
     MASCVGSRTL SKDDVNYKMH FRMINEQQVE DITIDFFYRP HTITLLSFTI VSLMYFAFTR
     DDSVPEDNIW RGILSVIFFF LIISVLAFPN GPFTRPHPAL WRMVFGLSVL YFLFLVFLLF
     LNFEQVKSLM YWLDPNLRYA TREADVMEYA VNCHVITWER IISHFDIFAF GHFWGWAMKA
     LLIRSYGLCW TISITWELTE LFFMHLLPNF AECWWDQVIL DILLCNGGGI WLGMVVCRFL
     EMRTYHWASF KDIHTTTGKI KRAVLQFTPA SWTYVRWFDP KSSFQRVAGV YLFMIIWQLT
     ELNTFFLKHI FVFQASHPLS WGRILFIGGI TAPTVRQYYA YLTDTQCKRV GTQCWVFGVI
     GFLEAIVCIK FGQDLFSKTQ ILYVVLWLLC VAFTTFLCLY GMIWYAEHYG HREKTYSECE
     DGTYSPEISW HHRKGTKGSE DSPPKHAGNN ESHSSRRRNR HSKSKVTNGV GKK
//
